Achieve Life Sciences, Inc. - Common Shares (ACHV) analyst actions
Rating and price-target actions on ACHV in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ACHV overview →
1 measured ACHV analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes | Press release | +0.56% | +0.38% |
Keep exploring
More ACHV: earnings → · SEC filings → · ACHV overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | 271 | -0.56% | 41% |
| PRESBIA PLC ORDINARY SHARES (LENS) | 270 | 0.00% | 42% |
| CorMedix Inc. (CRMD) | 269 | -0.42% | 39% |
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.